[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"biomarker:cdk4-gene":3},{"name":4,"total":5,"recruiting":5,"trials":6},"CDK4 Gene",7,[7,15,22,28,34,41,47],{"nct_id":8,"title":9,"phases":10,"status":12,"updated_at":13,"content_modified":14},"NCT04693468","Talazoparib and Palbociclib, Axitinib, or Crizotinib for the Treatment of Advanced or Metastatic Solid Tumors, TalaCom Trial",[11],"Phase 1","RECRUITING","2026-08-26T02:18:30.351130Z","2026-05-05T02:43:28.961863Z",{"nct_id":16,"title":17,"phases":18,"status":12,"updated_at":20,"content_modified":21},"NCT04469764","Abemaciclib for the Treatment of Recurrent Ovarian or Endometrial Cancer",[19],"Phase 2","2026-08-26T02:15:14.574786Z","2026-05-05T02:43:28.703321Z",{"nct_id":23,"title":24,"phases":25,"status":12,"updated_at":26,"content_modified":27},"NCT06025747","Evaluation of Abemaciclib and Radiation Therapy Before Surgery for the Treatment of High-Risk Adipocytic Retroperitoneal Sarcoma",[11],"2026-08-26T02:18:23.582895Z","2026-05-05T02:43:27.793904Z",{"nct_id":29,"title":30,"phases":31,"status":12,"updated_at":32,"content_modified":33},"NCT02523014","Vismodegib, FAK Inhibitor GSK2256098, Capivasertib, and Abemaciclib in Treating Patients With Progressive Meningiomas",[19],"2026-08-26T02:16:38.897933Z","2026-05-05T02:43:27.482521Z",{"nct_id":35,"title":36,"phases":37,"status":12,"updated_at":39,"content_modified":40},"NCT06726148","Study of ECI830 Single Agent or in Combination in Patients With Advanced HR+\u002FHER2- Breast Cancer and in Patients With Other Advanced Solid Tumors",[38],"Phase 1\u002FPhase 2","2026-08-26T02:18:14.396999Z","2026-07-19T19:36:05.056471Z",{"nct_id":42,"title":43,"phases":44,"status":12,"updated_at":45,"content_modified":46},"NCT05843253","Study of Ribociclib and Everolimus in HGG and DIPG or Ribociclib and Temozolomide in DHG, H3G34-mutant",[19],"2026-08-26T02:19:31.671303Z","2026-05-05T02:43:29.388169Z",{"nct_id":48,"title":49,"phases":50,"status":12,"updated_at":51,"content_modified":52},"NCT04040205","Abemaciclib for Bone and Soft Tissue Sarcoma With Cyclin-Dependent Kinase (CDK) Pathway Alteration",[19],"2026-08-26T02:18:07.037408Z","2026-05-05T02:43:28.417090Z"]